Resources from the same session
5239 - Health-related quality of life in patients with advanced soft tissue sarcoma (ASTS): Results from the TSAR randomized phase III trial of the French Sarcoma Group
Presenter: AXEL LE CESNE
Session: Poster Discussion session - Sarcoma
Resources:
Abstract
4912 - Health-related Quality of Life (HR-QoL) in elderly soft tissue sarcoma (STS) patients from the randomized phase II EPAZ study comparing pazopanib (PAZ) and doxorubicin (DOX) in first line
Presenter: Viktor Grünwald
Session: Poster Discussion session - Sarcoma
Resources:
Abstract
Slides
954 - Quality of Life in patients with soft tissue sarcoma undergoing palliative treatment - A multicenter, cluster-randomized trial within the Germany Interdisciplinary Sarcoma Group (GISG-12)
Presenter: Leopold Hentschel
Session: Poster Discussion session - Sarcoma
Resources:
Abstract
2951 - Immune response, safety, and overall survival of NY-ESO-1+ soft tissue sarcoma patients treated with CMB305 therapy
Presenter: Sant Chawla
Session: Poster Discussion session - Sarcoma
Resources:
Abstract
4012 - Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patients.
Presenter: Jean-Baptiste Delhorme
Session: Poster Discussion session - Sarcoma
Resources:
Abstract
3691 - Preoperative hypofractionated radiotherapy (RT) in patients with locally advanced myxoid liposarcomas: interim analysis of prospective phase II clinical trial
Presenter: Hanna Kosela Paterczyk
Session: Poster Discussion session - Sarcoma
Resources:
Abstract
4770 - A Phase II Study of pazopanib with Oral Topotecan in Patients with Metastatic Osteosarcoma
Presenter: Brian Van Tine
Session: Poster Discussion session - Sarcoma
Resources:
Abstract
4790 - A phase 2, multicenter study of the EZH2 inhibitor tazemetostat in adults (INI1-negative tumors cohort) (NCT02601950)
Presenter: Silvia Stacchiotti
Session: Poster Discussion session - Sarcoma
Resources:
Abstract
4830 - A phase 2, multicenter study of the EZH2 inhibitor tazemetostat in adults (rhabdoid tumor cohort) (NCT02601950)
Presenter: Robin Jones
Session: Poster Discussion session - Sarcoma
Resources:
Abstract
5047 - mTOR inhibitors in uterine and extra-uterine malignant PEComas: a multicenter international case series retrospective analysis.
Presenter: Roberta Sanfilippo
Session: Poster Discussion session - Sarcoma
Resources:
Abstract